Cited by 97Sleep and related disordersCOVID-19 and Mental HealthDigital Mental Health Interventions

Digital cognitive behavioral therapy for insomnia promotes later health resilience during the coronavirus disease 19 (COVID-19) pandemic

Open access
Cheng, Philip, Casement, Melynda D, Kalmbach, David A, Castelan, Andrea Cuamatzi, Drake, Christopher L·2021·Sleep

Abstract

Study Objectives: Stressful life events contribute to insomnia, psychosocial functioning, and illness. Though individuals with a history of insomnia may be especially vulnerable during stressful life events, risk may be mitigated by prior intervention. This study evaluated the effect of prior digital cognitive-behavioral therapy for insomnia (dCBT-I) versus sleep education on health resilience during the COVID-19 pandemic. Methods: COVID impact, insomnia, general- and COVID-related stress, depression, and global health were assessed in April 2020 in adults with a history of insomnia who completed a randomized controlled trial of dCBT-I (n = 102) versus sleep education control (n = 106) in 2016–2017. Regression analyses were used to evaluate the effect of intervention conditions on subsequent stress and health during the pandemic. Results: Insomnia symptoms were significantly associated with COVID-19 related disruptions, and those who previously received dCBT-I reported less insomnia symptoms, less general stress and COVID-related cognitive intrusions, less depression, and better global health than those who received sleep education. Moreover, the odds for resurgent insomnia was 51% lower in the dCBT-I versus control condition. Similarly, odds of moderate to severe depression during COVID-19 was 57% lower in the dCBT-I condition. Conclusions: Those who received dCBT-I had increased health resilience during the COVID-19 pandemic in adults with a history of insomnia and ongoing mild to moderate mental health symptoms. These data provide evidence that dCBT-I is a powerful tool to promote mental and physical health during stressors, including the COVID-19 pandemic. Clinical Trial Registration: NCT02988375

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/sleep/zsaa258

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In a randomized trial by Cheng and colleagues, the digital CBT-i group had significantly fewer insomnia symptoms, stress, cognitive intrusions, and depression than the education-only control during the pandemic.

    “The digital CBT-i group had significantly less insomnia symptoms, stress, cognitive intrusions and depression [12].”

    From Overview of sleep management during COVID-19. (2022) · cites this paper as [12]

    The Results sections on insomnia, stress, and health during COVID-19 report significantly lower insomnia symptoms, COVID-related cognitive intrusions, and depressive symptoms in the prior dCBT-I group than in the sleep-education control. COVID-specific stress was also significantly lower, but general stress showed only a trend (p = 0.055), so the claim overstates the significance of the general-stress finding. (LLM, conf=0.90)

    Experimental — accuracy not yet measured
  • For specific management of COVID-19 sleep dysfunction, five CBT studies were available: two controlled insomnia trials, one worry/secondary insomnia study, one case study, and one small online child study.

    “As to specific management of sleep dysfunction during COVID-19, five studies of cognitive behavioral therapy (CBT) were available – two controlled trials of insomnia [11,12], one focused on worry and secondary insomnia [13], one case study [14] and a small online study in children [15].”

    From Overview of sleep management during COVID-19. (2022) · cites this paper as [12]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 61

  1. [4]Rajkumar RP. COVID-19 and mental health: a review of the existing literature. Asian J Psychiatr. 2020; 52: 102066. 32302935 PMC7151415
  2. [5]Cellini N, et al Changes in sleep pattern, sense of time and digital media use during COVID-19 lockdown in Italy. J Sleep Res. 2020; 29(4): e13074. 32410272 PMC7235482
  3. [12]Germain A, et al Sleep in PTSD: conceptual model and novel directions in brain-based research and interventions. Curr Opin Psychol. 2017; 14: 84– 89. 28813325
  4. [13]Manber R, et al Insomnia and depression: a multifaceted interplay. Curr Psychiatry Rep. 2009; 11(6): 437– 442. 19909664
  5. [14]Vargas I, et al Insomnia and depression: clinical associations and possible mechanistic links. Curr Opin Psychol. 2020; 34: 95– 99. 31846870 PMC12172691
  6. [16]Hertenstein E, et al Insomnia as a predictor of mental disorders: a systematic review and meta-analysis. Sleep Med Rev. 2019; 43: 96– 105. 30537570
  7. [17]Pigeon WR, et al Insomnia as a precipitating factor in new onset mental illness: a systematic review of recent findings. Curr Psychiatry Rep. 2017; 19(8): 44. 28616860
  8. [18]Li L, et al Insomnia and the risk of depression: a meta-analysis of prospective cohort studies. BMC Psychiatry. 2016; 16(1): 375. 27816065 PMC5097837
  9. [19]Soehner AM, et al Prevalence and clinical correlates of co-occurring insomnia and hypersomnia symptoms in depression. J Affect Disord. 2014; 167: 93– 97. 24953480 PMC4291280
  10. [20]O’Brien EM, et al Severe insomnia is associated with more severe presentation and greater functional deficits in depression. J Psychiatr Res. 2011; 45(8): 1101– 1105. 21306733
  11. [22]Brownlow JA, et al Influence of sleep disturbance on global functioning after posttraumatic stress disorder treatment. J Trauma Stress. 2016; 29(6): 515– 521. 27859588
  12. [23]Mason EC, et al Insomnia before and after treatment for anxiety and depression. J Affect Disord. 2014; 168: 415– 421. 25108278
  13. [24]Pigeon WR, et al Longitudinal relationships of insomnia, nightmares, and PTSD severity in recent combat veterans. J Psychosom Res. 2013; 75(6): 546– 550. 24290044
  14. [25]Schnurr PP, et al Residual symptoms following prolonged exposure and present-centered therapy for PTSD in female veterans and soldiers. Depress Anxiety. 2019; 36(2): 162– 169. 30576030
  15. [26]Larsen SE, et al Residual symptoms following empirically supported treatment for PTSD. Psychol Trauma. 2019; 11(2): 207– 215. 29963892
  16. [27]Xiao L, et al Comparison of residual depressive symptoms and functional impairment between fully and partially remitted patients with major depressive disorder: a multicenter study. Psychiatry Res. 2018; 261: 547– 553. 29407721
  17. [30]Kalmbach DA, et al Sleep system sensitization: evidence for changing roles of etiological factors in insomnia. Sleep Med. 2016; 21: 63– 69. 27448474 PMC4963610
  18. [31]Morin CM, et al Role of stress, arousal, and coping skills in primary insomnia. Psychosom Med. 2003; 65(2): 259– 267. 12651993
  19. [32]Palagini L, et al Lack of resilience is related to stress-related sleep reactivity, hyperarousal, and emotion dysregulation in insomnia disorder. J Clin Sleep Med. 2018; 14(5): 759– 766. 29734989 PMC5940426
  20. [33]Ebert DD, et al It is time to invest in the prevention of depression. JAMA Netw Open. 2018; 1(2): e180335. 30646081
  21. [34]Germain A, et al Sleep and resilience—a call for prevention and intervention. Sleep. 2016; 39(5): 963– 965. 27091522 PMC4835317
  22. [35]Taylor DJ, et al Insomnia as a health risk factor. Behav Sleep Med. 2003; 1(4): 227– 247. 15600216
  23. [36]Dolsen MR, et al Insomnia as a transdiagnostic process in psychiatric disorders. Curr Psychiatry Rep. 2014; 16(9): 471. 25030972 PMC4185311
  24. [37]Qaseem A, et al; Clinical Guidelines Committee of the American College of Physicians. Management of chronic insomnia disorder in adults: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2016; 165(2): 125– 133. 27136449
  25. [39]Cheng P, et al Efficacy of digital CBT for insomnia to reduce depression across demographic groups: a randomized trial. Psychol Med. 2019; 49(3): 491– 500. 29792241 PMC7050476
  26. [40]Pillai V, et al. The anxiolytic effects of cognitive behavior therapy for insomnia: preliminary results from a web-delivered protocol. J Sleep Med Disord. 2015; 2(2): 1017. 32195356 PMC7081886
  27. [41]Cheng P, et al Depression prevention in digital cognitive behavioral therapy for insomnia: Is rumination a mediator? J Affect Disord. 2020; 273: 434– 441. 32560938
  28. [43]Espie CA, et al Effect of digital cognitive behavioral therapy for insomnia on health, psychological well-being, and sleep-related quality of life: a randomized clinical trial. JAMA Psychiatry. 2019; 76(1): 21– 30. 30264137 PMC6583463
  29. [44]Cheng P, et al Depression prevention via digital CBT for insomnia: a randomized controlled trial. Sleep. 2019; 42(10). doi: 10.1093/sleep/zsz150. PMC6783888 31535688 · DOI
  30. [45]Cheng P, et al Efficacy of digital CBT for insomnia to reduce depression across demographic groups: a randomized trial. Psychol Med. 2018; 49(3): 491– 500. 29792241 PMC7050476
  31. [48]Espie CA, et al The daytime impact of DSM-5 insomnia disorder: comparative analysis of insomnia subtypes from the Great British Sleep Survey. J Clin Psychiatry. 2012; 73(12): e1478– 84. 23290331
  32. [49]Gray MJ, et al Psychometric properties of the life events checklist. Assessment. 2004; 11(4): 330– 341. 15486169
  33. [51]Elo A-L, et al Validity of a single-item measure of stress symptoms. Scand J Work Environ Health. 2003; 444– 451. 14712852
  34. [52]Salminen S, et al Is a single item stress measure independently associated with subsequent severe injury: a prospective cohort study of 16,385 forest industry employees. BMC Public Health. 2014; 14(1): 543. 24884543 PMC4047775
  35. [53]Weiss DS, et al The impact of event scale-revised. In: Wilson JP, Keane TM, eds. Assessing Psychological Trauma and PTSD. New York: Guilford Press; 1997: 399– 411.
  36. [54]Rush AJ, et al The 16-Item quick inventory of depressive symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biol Psychiatry. 2003; 54(5): 573– 583. doi: 10.1016/S0006-3223(02)01866-8 12946886 · DOI · Paper page
  37. [56]Zhao Q, et al BETS: the dangers of selection bias in early analyses of the coronavirus disease (COVID-19) pandemic. ArXiv Prepr ArXiv200407743. 2020.
  38. [57]Sullivan SG. The need for robust epidemiological evidence during a pandemic. Clin Infect Dis. 2020. PMC7454378 32544943
  39. [58]Kalmbach DA, et al Treating insomnia improves depression, maladaptive thinking, and hyperarousal in postmenopausal women: comparing cognitive-behavioral therapy for insomnia (CBTI), sleep restriction therapy, and sleep hygiene education. Sleep Med. 2019; 55: 124– 134. 30785053 PMC6503531
  40. [61]Batterham PJ, et al Trajectories of change and long-term outcomes in a randomised controlled trial of internet-based insomnia treatment to prevent depression. BJPsych Open. 2017; 3(5): 228– 235. doi: 10.1192/bjpo.bp.117.005231. 28959453 PMC5611538 · DOI
  41. [62]Nano M-M, et al Measures of cardiovascular autonomic activity in insomnia disorder: A systematic review. PLoS One. 2017; 12(10): e0186716. doi: 10.1371/journal.pone.0186716. 29059210 PMC5653329 · DOI
  42. [63]Dodds KL, et al Heart rate variability in insomnia patients: A critical review of the literature. Sleep Med Rev. 2017; 33: 88– 100. doi: 10.1016/j.smrv.2016.06.004. 28187954 · DOI
  43. [64]Carter JR, et al Assessment of sympathetic neural activity in chronic insomnia: evidence for elevated cardiovascular risk. Sleep. 2018; 41(6). doi: 10.1093/sleep/zsy048. PMC5995193 29522186 · DOI
  44. [65]Jarrin DC, et al Cardiovascular autonomic dysfunction in insomnia patients with objective short sleep duration. J Sleep Res. 2018; 27(3): e12663. doi: 10.1111/jsr.12663. 29493063 PMC5992004 · DOI
  45. [68]Kuisk LA, et al Presleep cognitive hyperarousal and affect as factors in objective and subjective insomnia. Percept Mot Skills. 1989; 69(3-2): 1219– 1225. doi: 10.1177/00315125890693-228. 2622737 · DOI
  46. [69]Bonnet MH, et al Hyperarousal and insomnia: State of the science. Sleep Med Rev. 2010; 14(1): 9– 15. doi: 10.1016/j.smrv.2009.05.002. 19640748 · DOI · Paper page
  47. [70]Kalmbach DA, et al Hyperarousal and sleep reactivity in insomnia: current insights. Nat Sci Sleep. 2018; 10: 193– 201. doi: 10.2147/NSS.S138823. 30046255 PMC6054324 · DOI
  48. [72]Levenson JC, Kay DB, Buysse DJ. The pathophysiology of insomnia. Chest. 2015; 147(4): 1179– 1192. doi: 10.1378/chest.14-1617. 25846534 PMC4388122 · DOI
  49. [73]Riemann D, et al The neurobiology, investigation, and treatment of chronic insomnia. Lancet Neurol. 2015; 14(5): 547– 558. doi: 10.1016/S1474-4422(15)00021-6. 25895933 · DOI
  50. [74]Irwin MR, et al Cognitive behavioral therapy and Tai Chi reverse cellular and genomic markers of inflammation in late-life insomnia: a randomized controlled trial. Biol Psychiatry. 2015; 78(10): 721– 729. doi: 10.1016/j.biopsych.2015.01.010. 25748580 PMC4524803 · DOI · Paper page
  51. [75]Marques DR, et al Neurobiological correlates of psychological treatments for insomnia. Eur Psychol. 2016; 21(3): 195- 205. doi: 10.1027/1016-9040/a000264. · DOI
  52. [76]Casement MD, et al Neural reward processing mediates the relationship between insomnia symptoms and depression in adolescence. Sleep. 2016; 39(2): 439– 447. doi: 10.5665/sleep.5460. 26350468 PMC4712408 · DOI
  53. [78]Ancoli-Israel S, et al Characteristics of insomnia in the United States: results of the 1991 National Sleep Foundation Survey. I. Sleep. 1999; 22(Suppl 2): S347– S353. 10394606
  54. [79]Sarsour K, et al The association between insomnia severity and healthcare and productivity costs in a health plan sample. Sleep. 2011; 34(4): 443- 450. doi: 10.1093/sleep/34.4.443. 21461322 PMC3065254 · DOI
  55. [80]Stoller MK. Economic effects of insomnia. Clin Ther Int Peer-Rev J Drug Ther. 1994; 16(5): 873– 897. 7859246
  56. [81]McCrae Christina S, et al Impact of brief cognitive behavioral treatment for insomnia on health care utilization and costs. J Clin Sleep Med. 2014; 10(2): 127- 135. doi: 10.5664/jcsm.3436. 24532995 PMC3899314 · DOI
  57. [82]Snedecor SJ, et al Cost-effectiveness of Eszopiclone for the treatment of adults with primary chronic insomnia. Sleep. 2009; 32(6): 817- 824. doi: 10.1093/sleep/32.6.817. 19544759 PMC2690570 · DOI
  58. [83]Jhaveri M, et al Will insomnia treatments produce overall cost savings to commercial managed-care plans? a predictive analysis in the United States. Curr Med Res Opin. 2007; 23(6): 1431- 1443. doi: 10.1185/030079907X199619. 17559740 · DOI
  59. [84]Asche CV, et al The direct costs of untreated comorbid insomnia in a managed care population with major depressive disorder. Curr Med Res Opin. 2010; 26(8): 1843- 1853. doi: 10.1185/03007995.2010.488037. 20515321 · DOI
  60. [85]Bramoweth AD, et al Chronic insomnia and health care utilization in young adults. Behav Sleep Med. 2012; 10(2): 106- 121. doi: 10.1080/15402002.2011.587067. 22468929 · DOI
  61. [86]Ho FY-Y, et al Self-help cognitive-behavioral therapy for insomnia: a meta-analysis of randomized controlled trials. Sleep Med Rev. 2015; 19: 17- 28. doi: 10.1016/j.smrv.2014.06.010. 25104471 · DOI

Cited by

Sorted by citations

Authors
Cheng, P., Casement, M. D., Kalmbach, D. A., Castelan, A. C., & Drake, C. L.
Affiliations
  • Henry Ford Health (US)
  • University of Oregon (US)
Corresponding author
Cheng, Philip
Venue
Sleep
Published
2020-11-29
Volume
44
Issue
4
ISSN
  • 0161-8105 (ISSN-L)
  • 1550-9109
OpenAlex
W3109523581
Cited by
97
References
22
Citations by year
2026: 2 · 2025: 12 · 2024: 13 · 2023: 23 · 2022: 27 · 2021: 20
FWCI
16.93
Type
journal article
Language
en
Open access
Locations
  • SLEEP (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Heart, Lung, and Blood Institute
Topics
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and related disorders
  • Social Sciences › Psychology › Clinical Psychology › COVID-19 and Mental Health
  • Social Sciences › Psychology › Applied Psychology › Digital Mental Health Interventions
Keywords
digital cognitive behavioral therapy for insomnia, insomnia, health resilience, COVID-19 pandemic, stress, depression, sleep education, mental health, global health
MeSH terms
COVID-19, SARS-CoV-2, Adult, Depression, Humans, Sleep Initiation and Maintenance Disorders, Cognitive Behavioral Therapy, Treatment Outcome, Pandemics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review